Tirzepatide and GLP-1 receptor agonists are replacing older treatments, marking a shift in how diabetes and weight loss are ...

Tirzepatide is approved for 3 indications in the US: type 2 diabetes, chronic weight management, and obstructive sleep apnea.

When it comes to managing weight loss and type 2 diabetes with medications, research shows that it's out with the old and in with the new.

When it comes to managing weight loss and type 2 diabetes with medications, research shows that it's out with the old and in ...

Delirium is a sudden and serious condition that causes confusion and a lack of awareness. It often happens quickly, ...

Researchers at the University of Helsinki have found that metformin can activate certain immune cells, making them better at spotting and attacking cancer. The findings, published in the Journal for ...

At the end of 2023, more than one-third of new prescriptions to treat Type 2 diabetes were GLP-1s, such as Mounjaro and Ozempic, among others, according to a study published April 15 in Annals of ...

India has a high prediabetes prevalence (15.3%), nearly equal in urban (15.4%) and rural (15.2%) areas. (1) In India, ...

The study funding process came to a halt when the Trump administration announced the cancellation of roughly $400 million in ...

HighTide Therapeutics Announces HTD1801 Meets the Primary Endpoints in Two Phase 3 Clinical Trials in Patients with Type 2 Diabetes Mellitus HONG KONG - April 15, 2025 (NEWMEDIAWIRE) - HighTide ...

Researchers have found in a new research that Metformin shows promise in promoting periodontal tissue repair following ...

Weight gain, thinning hair, and trouble getting pregnant are common, too, often tied to insulin resistance — a glitch causing ...